The US Wound Care Management Devices Market is Segmented by Product (Wound Care [Dressings, Wound-Care Devices, and More] and Wound Closure [Sutures, Surgical Staplers, and More]), Wound Type (Chronic Wounds and Acute Wounds), End User (Hospitals & Specialty Wound Clinics and More), and Mode of Purchase (Institutional Procurement and Retail / OTC Channel). The Market and Forecasts are Provided in Terms of Value (USD).

US Wound Care Market size is estimated to reach USD 13.31 Billion by 2035, at a CAGR of 3.8% during the projected period

Snapshot img

Wound Care Market Size 2024-2028

The wound care market size is valued to increase USD 6.95 billion, at a CAGR of 5.8% from 2023 to 2028. Increasing prevalence of acute and chronic wounds will drive the wound care market.

Major Market Trends & Insights

North America dominated the market and accounted for a 38% growth during the forecast period.
By Product - Advanced wound dressings segment was valued at USD 7.21 billion in 2022
By Application - Chronic wound segment accounted for the largest market revenue share in 2022

Market Size & Forecast

Market Opportunities: USD 57.53 million
Market Future Opportunities: USD 6952.40 million
CAGR : 5.8%
North America: Largest market in 2022

Market Summary

The market encompasses a continually evolving landscape shaped by advancements in core technologies and applications, service types, and product categories. With the increasing prevalence of acute and chronic wounds, the demand for combination wound dressings is on the rise. These dressings offer benefits such as improved patient comfort and faster healing times. However, the high cost of wound treatments and advanced wound care products poses a significant challenge for market growth. Regions like Europe and North America are witnessing substantial market activity, with Europe accounting for over 40% of the global market share due to its aging population and increasing healthcare expenditures. This dynamic market is further influenced by regulatory bodies such as the FDA and EMA, which ensure stringent safety and efficacy standards for wound care products.

What will be the Size of the Wound Care Market during the forecast period?

Get Key Insights on Market Forecast (PDF) Request Free Sample

How is the Wound Care Market Segmented and what are the key trends of market segmentation?

The wound care industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments. ProductAdvanced wound dressingsSurgical wound careTraditional wound careApplicationChronic woundAcute woundEnd UserHospitalsSpecialty ClinicsHome Care SettingsHospitalsSpecialty ClinicsHome Care SettingsDistribution ChannelInstitutional SalesRetail SalesInstitutional SalesRetail SalesGeographyNorth AmericaUSCanadaEuropeFranceGermanyItalyUKMiddle East and AfricaEgyptKSAOmanUAEAPACChinaIndiaJapanSouth AmericaArgentinaBrazilRest of World (ROW)

By Product Insights

The advanced wound dressings segment is estimated to witness significant growth during the forecast period.

Advanced wound care solutions have gained significant traction in the healthcare industry due to the increasing prevalence of chronic wounds and burns. Among various advanced wound care products, advanced wound dressings have emerged as a leading segment, accounting for a substantial market share. These dressings encompass moist wound dressings and antimicrobial wound dressings. The advanced wound dressings segment's revenue growth can be attributed to several factors. The rising number of surgical procedures, increasing awareness about the clinical benefits of advanced wound dressings, and the growing aging population are primary drivers. Moreover, the adoption of advanced wound dressings in hospitals and wound care clinics and new product launches have further fueled market expansion. Despite these growth opportunities, the advanced wound dressings segment faces challenges. Intense competition among companies, high product costs, and the limited scope for differentiation leading to price wars adversely impact the market. The chronic wound management market is projected to expand at a brisk pace. According to estimates, the chronic wound management segment is expected to grow by 18.3% by 2025. Similarly, the tissue regeneration technologies segment is anticipated to grow by 15.5% during the same period. Pressure ulcer prevention, arterial ulcer treatment, and infection control protocols are crucial aspects of wound care. Topical antimicrobial agents, hydrogel wound dressings, and silver dressings antimicrobial play a vital role in infection control. Debridement techniques' efficacy and pain management strategies are also essential considerations in advanced wound care. Bioengineered skin substitutes, reconstructive surgery techniques, and collagen matrix dressings are other advanced wound care solutions gaining popularity. Hyperbaric oxygen therapy, ulcerative colitis treatment, and wound healing assessment are additional applications of advanced wound care solutions. In conclusion, the market is a dynamic and evolving landscape. Market trends include the growing adoption of advanced wound care solutions, increasing awareness about wound care, and the development of new technologies. Despite challenges, the mar

The U.S. Advanced Wound Care Marketsize was valued at USD 4.22 USD Billion in 2023 and is projected to reach USD 6.18 USD Billion by 2032, exhibiting a CAGR of 5.6 % during the forecast period. Key drivers for this market are: Increasing Adoption of Synthetic BVF to Boost Market Growth. Potential restraints include: Increase in Product Recalls to Hamper the Market Growth. Notable trends are: Increasing Number of Hospitals and ASCs Identified as Significant Market Trend.

The US wound care management devices market, a significant segment of the global healthcare industry, is experiencing steady growth fueled by an aging population, increasing prevalence of chronic diseases like diabetes and obesity leading to higher incidence of chronic wounds, and advancements in wound care technologies. The market is characterized by a diverse range of products, including wound dressings, wound closure devices (sutures, staples, adhesives), and topical agents. The chronic wound segment, encompassing diabetic foot ulcers, pressure ulcers, and venous ulcers, dominates market share due to the long-term care requirements and associated higher costs. Acute wound management, encompassing surgical wounds and burns, also contributes significantly, driven by the increasing number of surgical procedures and burn injuries. Key players like Medtronic, 3M, Smith & Nephew, and Johnson & Johnson hold substantial market share, leveraging their established distribution networks and strong brand recognition. Competition is intense, with companies focusing on innovation, particularly in advanced wound dressings (e.g., those incorporating growth factors or antimicrobial agents) and minimally invasive wound closure techniques. The market's growth is projected to remain stable, albeit with a moderate CAGR, reflecting the ongoing need for effective wound care solutions and ongoing technological advancements. However, factors such as high healthcare costs and reimbursement challenges present potential restraints to market expansion. Future growth will likely be driven by increased adoption of advanced wound care technologies, particularly in the home healthcare setting, and expanding access to specialized wound care services in underserved areas. The market is segmented geographically, with North America representing a significant portion of the overall market share due to factors such as high healthcare expenditure, advanced healthcare infrastructure, and strong presence of key market players. Growth in other regions like Asia Pacific is expected to be driven by rising healthcare awareness, increasing disposable incomes, and improving healthcare infrastructure. Europe also represents a substantial market, influenced by similar factors although at a potentially slower growth rate compared to the Asia Pacific region. Overall, the US wound care management devices market presents a robust and dynamic landscape, characterized by a blend of established players and emerging technologies, poised for continued growth driven by both demographic shifts and technological advancements in wound care. Recent developments include: April 2023: 3M Health Care's innovative 3M Veraflo Therapy, with both 3M Veraflo Cleanse Choice Complete Dressing and 3M™ V.A.C. Veraflo Cleanse Choice Dressing, received the first-ever Food and Drug Administration (FDA) clearance for hydromechanical removal of infectious materials, non-viable tissue and wound debris which reduces the number of surgical debridements required, while promoting granulation tissue formation, creating an environment that promotes wound healing., January 2023: Convatec launched the ConvaFoam, a family of advanced foam dressings designed to address the needs of healthcare providers and their patients in the United States. ConvaFoam can be used on a spectrum of wound types at any stage of the wound journey, making it the simple dressing choice for wound management and skin protection.. Key drivers for this market are: Increasing Incidences of Chronic Wounds, Ulcers and Diabetic Ulcers, Increase in the Number of Surgical Procedures; Rising Aging Population. Potential restraints include: Increasing Incidences of Chronic Wounds, Ulcers and Diabetic Ulcers, Increase in the Number of Surgical Procedures; Rising Aging Population. Notable trends are: Sutures Segment is Expected to Grow Significantly Over the Forecast Period.

US Wound Care Management Devices Market size was valued at USD 8.1 Billion in 2024 and is projected to reach USD 15.0 Billion by 2032, growing at a CAGR of 8% from 2026 to 2032.

Aging Population and Increased Healthcare: The aging population and increased healthcare needs will drive the U.S. wound care management devices market. By 2030, every baby boomer will be 65 or older, increasing the population's susceptibility to chronic wounds and complex healing. The 65+ population is estimated to reach 74.1 million by 2030, a 22% rise from 2020, resulting in increased demand for specialized wound care solutions. This generational transition, together with advances in wound care technologies, will fuel innovation and market expansion in the coming years. Increasing Chronic Wound Prevalence: The increasing prevalence of chronic wounds will have a substantial impact on the wound care management devices industry in the United States.

The U.S. Advanced Wound Care Market size was valued at USD 844.51 million in 2023 and is projected to reach USD 1222.80 million by 2032, exhibiting a CAGR of 5.43 % during the forecasts period. Advanced wound care can therefore be defined as a variety of specialized therapeutic interventions that can enhance wound healing and the management of difficult wounds compared to traditional means. Such treatments include hydrocolloids, alginates, antimicrobial dressings, bioengineered tissue, negative pressure wound therapy (NPWT), and hyperbaric oxygen therapy. The principles of advanced wound care include maintaining a moist wound environment, controlling exudate, reducing infection risk, and supporting tissue repair. All these features contribute immensely to the healing process by providing a favorable environment for cellular repair and minimizing the chances of developing complications. There are numerous benefits to advanced wound care. It decreases the time taken during treatment and overall healthcare expenses. The patient has less pain and discomfort, and the infection rate and scarring are minimal. The demand for advanced wound care in the U.S. is driven by an aging population, increasing chronic diseases, advancements in technology, rising surgical procedures, and heightened awareness of effective wound management.

The size of the US Wound Care Management Devices Industry market was valued at USD XX Million in 2023 and is projected to reach USD XXX Million by 2032, with an expected CAGR of 3.39% during the forecast period. Recent developments include: April 2023: 3M Health Care's innovative 3M Veraflo Therapy, with both 3M Veraflo Cleanse Choice Complete Dressing and 3M™ V.A.C. Veraflo Cleanse Choice Dressing, received the first-ever Food and Drug Administration (FDA) clearance for hydromechanical removal of infectious materials, non-viable tissue and wound debris which reduces the number of surgical debridements required, while promoting granulation tissue formation, creating an environment that promotes wound healing., January 2023: Convatec launched the ConvaFoam, a family of advanced foam dressings designed to address the needs of healthcare providers and their patients in the United States. ConvaFoam can be used on a spectrum of wound types at any stage of the wound journey, making it the simple dressing choice for wound management and skin protection.. Key drivers for this market are: Increasing Incidences of Chronic Wounds, Ulcers and Diabetic Ulcers, Increase in the Number of Surgical Procedures; Rising Aging Population. Potential restraints include: Concerns with Stringent Regulations and Reimbursement Policies, High Treatment Costs. Notable trends are: Sutures Segment is Expected to Grow Significantly Over the Forecast Period.

The size of the Advanced Wound Care Market in North America market was valued at USD 5.34 Million in 2023 and is projected to reach USD 6.79 Million by 2032, with an expected CAGR of 3.50% during the forecast period. The North America advanced wound care market is concerned with the care of complicated, chronic, and non-healing wounds – such as diabetic ulcers, pressure ulcers, and post-surgical complications. It includes topical solutions, sophisticated dressings, wound management devices, and accident biologics that cut the time to healing and minimize infections’ probability in the wound. Main uses are in hospitals, repute care centres, and home care services. Major factors affecting the market include a growing incidence of diseases, change in the population’s demography, and a rise in the number of surgical operations. Contemporary trends focus on products such as the bioengineered skin substitutes, growth factors, and antimicrobial dressing. Similarly, increasing innovations in the wound healing devices including negative pressure wound therapy (NPWT) are also driving the market. Recent developments include: In October 2022, Wounds Canada and the Registered Nurses Association of Ontario (RNAO) planned to launch the Wound Care Champion Program (WCCP), designed to deliver evidence-informed, interdisciplinary, proficient-level wound education for front-line clinicians. The program will train regulated health professionals in Ontario, with 200 spots to be funded by the provincial Ministry of Health., In September 2022, Arch Therapeutics, Inc., a developer of novel self-assembling wound care and bio-surgical products, launched a multi-site clinical study to accelerate payor adoption and differentiate the benefits of the AC5 Advanced Wound System in treating challenging wounds. The Study launch completes the near-term commitments listed in the Company's recently announced reimbursement initiative to accelerate sales opportunities for AC5 in doctor's offices and wound care clinics.. Key drivers for this market are: Increase in the Geriatric Population, Rising Incidences of Chronic Wound. Potential restraints include: High-cost and Risk associated with Advanced Products. Notable trends are: Suture Sub-segment by Wound Closure Segment is Expected to Grow Over the Forecast Period.

The U.S. Wound Care Market size was valued at USD 6.14 USD billion in 2023 and is projected to reach USD 9.42 USD billion by 2032, exhibiting a CAGR of 6.3 % during the forecast period. Key drivers for this market are: Increasing Prevalence of Chronic Diseases and Introduction of Innovative Devices to Drive the Demand for C-arms . Potential restraints include: Recent Product Recalls to Limit the Market Growth. Notable trends are: Increasing Number of Hospitals and ASCs Identified as Significant Market Trend.

Snapshot img

Chronic Wound Care Market Size 2024-2028

The chronic wound care market size is forecast to increase by USD 5.44 billion at a CAGR of 6.52% between 2023 and 2028.

Chronic wounds, including surgical wounds and trauma wounds, pose a significant challenge to healthcare systems due to their prevalence and high treatment costs. Factors such as wound infections, compromised immune function, and poor circulation contribute to the complexity of managing these wounds. In response, the market for chronic wound care solutions is witnessing notable trends, including the increasing adoption of advanced wound care technologies like moist wound dressings. Hospitals and specialty clinics are integrating wound care teams to improve patient outcomes and reduce healthcare costs. However, the high expense of chronic wound treatment remains a significant challenge for both providers and patients.

What will be the Size of the Market During the Forecast Period?

Request Free Sample

The market represents a significant and growing segment within the healthcare industry. Chronic wounds, such as those resulting from diabetes, pressure ulcers, venous ulcers, arterial ulcers, and other chronic diseases including cancer and autoimmune diseases, present unique challenges for effective treatment and healing. Chronic diseases, including diabetes, are a leading cause of chronic wounds. Diabetes-related foot ulcers alone account for a substantial portion of chronic wounds, with an estimated 15% of people with diabetes developing a foot ulcer at some point in their lives.



Another significant contributor to chronic wounds is the changing lifestyle trends, leading to an increase in obesity, sedentary lifestyles, and unhealthy diets. These factors can result in a higher incidence of chronic wounds, particularly pressure ulcers, which affect individuals with limited mobility and those requiring extended hospital stays. The rising prevalence of chronic wounds is driving demand for advanced wound care solutions. Medical devices, such as medical tapes, bandages, and wound dressings, play a crucial role in the treatment and management of chronic wounds. These products are designed to promote wound healing, protect against infection, and provide a comfortable and secure covering for the wound.

How is this market segmented and which is the largest segment?

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

Product

  Advanced dressing
  Traditional wound care
  Surgical wound care
  Wound therapy devices


Application

  Diabetic foot ulcers
  Pressure ulcers
  Venous leg ulcers


Geography

  North America

    US


  Europe

    Germany
    UK
    France


  Asia

    Japan


  Rest of World (ROW)

By Product Insights

The advanced dressing segment is estimated to witness significant growth during the forecast period.

In the realm of chronic wound care, various supplies play a pivotal role in ensuring optimal healing. Among these, sterilization supplies and hand sanitizers are essential for maintaining a clean and hygienic environment. Obesity is a significant contributor to chronic wounds, particularly in the form of lower extremity amputations. Advanced wound dressings, such as hydrocolloid, gel, film, alginate, and foam dressings, are utilized to protect the surrounding tissue and wound base. These dressings absorb exudate or hold onto moisture, enabling the wound to heal effectively. Advanced wound dressings, like alginate, offer high absorbency and transform into a gel upon contact with the wound surface.

Furthermore, this gel can be effortlessly removed with a dressing or washed off with sterile saline. Traditional wound dressings and surgical wound dressings also hold importance in wound care. Wound therapy devices, such as negative pressure wound therapy and electrical stimulation, further enhance the healing process. The market for chronic wound care supplies is segmented into the hospital segment and home healthcare segment. The hospital segment accounts for a larger share due to the availability of advanced medical facilities and specialized care. The home healthcare segment is expected to witness significant growth due to the increasing trend of home-based healthcare and the convenience it offers to patients.

Get a glance at the market report of share of various segments Request Free Sample

The advanced dressing segment was valued at USD 4.41 billion in 2018 and showed a gradual increase during the forecast period.

Regional Analysis

North America is estimated to contribute 44% to the growth of the global market during the forecast period.

Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during th

The Latin America advanced wound care market was valued at USD 816.30 Million in 2024, driven by the improving healthcare access, accelerating the development of hospitals and primary healthcare centres across the region. The market is anticipated to grow at a CAGR of 4.00% during the forecast period of 2025-2034 to achieve a value of USD 1208.32 Million by 2034.

Global Bioactive Wound Care Market size is expected to be worth around US$ 25.1 Billion by 2034 from US$ 12.2 Billion in 2024.

The market offers a diverse range of dressings, categorized by their material and properties: foam, silicone, hydrocolloid, and hydrogel dressings each cater to specific wound types and healing stages. Beyond dressings, the market encompasses a variety of devices and accessories that significantly impact wound management. Negative pressure wound therapy (NPWT) systems accelerate healing, while advanced debridement devices efficiently remove necrotic tissue. Furthermore, sophisticated wound assessment tools enable precise monitoring and optimized treatment strategies, contributing to improved patient outcomes and reduced healthcare costs. Recent developments include: July 2023: With an upfront cash payment of USD 1.2 billion, Coloplast has agreed to pay up to USD 1.3 billion for the acquisition of Kerecis, a creative and quickly expanding firm in the biologics wound care space. Entering the high-growth, US-centric biologics sector through Kerecis offers Coloplast a strategic opportunity to strengthen its position in the advanced wound care market., January 2022: Convatec Group acquired Triad Life Sciences Inc. to get entry into the lucrative wound biologics market. Convatec's Advanced Wound Care division in the US is anticipated to benefit from this, as their highly complementary product portfolios and business acumen will improve the company.. Notable trends are: Rising prevalence of acute and chronic wounds will boost the market growth.

The global chronic wound care market is estimated to be valued at USD 18.6 billion in 2025 and is projected to reach USD 26.7 billion by 2035, registering a compound annual growth rate (CAGR) of 3.7% over the forecast period.

Country-wise Insights

The global veterinary wound care market was valued at US$ 1.1 Billion in 2022 and is expected to reach US$ 2.8 Billion by 2033. The surgical wound care products segment with a market share of more than 61.0% has topped the global market within the product category in 2022 and is expected to grow at a CAGR of close to 8.5% over the forecast period (2023 to 2033).

Report Scope as Per Veterinary Wound Care Industry Analysis

In US Advanced Wound Care Market, offering valuable insights, key market trends, competitive landscape, and future outlook to support strategic decision.

The Active Wound Care Market Report is Segmented by Product (Biomaterials, Skin Substitutes, Growth Factors), End User (Hospitals, Specialty Wound Clinics, Home Healthcare, Others), Application (Chronic Wounds, Acute Wounds), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America). The Market Forecasts are Provided in Terms of Value (USD).

The U.S. Wound Care Market size was valued at USD 8.97 billion in 2023 and is projected to reach USD 11.89 billion by 2032, exhibiting a CAGR of 4.11 % during the forecasts period.

Europe Surgical Wound Care Market size was valued at USD 129.36 Million in 2024 and is projected to reach USD 157.62 Million by 2032, growing at a CAGR of 5.83% from 2025 to 2032.US Surgical Wound Care Market size was valued at USD 1,962.88 Million in 2024 and is projected to reach USD 2,596.02 Million by 2032, growing at a CAGR of 4.82% from 2025 to 2032.The U.S. and Europe surgical wound care market is driven by several key factors that contribute to its growth and development. The increasing number of surgical procedures being performed in these regions is a significant driver. With the rise in chronic diseases, an aging population, and advancements in surgical techniques, the demand for surgical interventions has significantly increased. Healthcare-associated infections can significantly influence patient outcomes and increase healthcare costs. Therefore, there is a heightened focus on implementing stringent infection control measures, including proper surgical wound care protocols. This drives the demand for advanced wound care products that help minimize the risk of surgical site infections and promote faster healing. Healthcare providers are recognizing the impact of optimal wound management on patient recovery and are actively seeking innovative products and solutions.